Literature DB >> 8764135

Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells.

S Shimizu1, Y Nishikawa, K Kuroda, S Takagi, K Kozaki, S Hyuga, S Saga, M Matsuyama.   

Abstract

We have reported previously that highly metastatic LuM1 cells derived from colon carcinoma colon 26 secrete larger amounts of gelatinase B than NM11 cells with poor metastatic potential, and that an increase in this gelatinase B secretion can be induced by autocrine factors (Hyup et A, Cancer Res., 54: 3611-3616, 1994). In the present study, a partial characterization was achieved by comparison of the autocrine factor preparation (fraction G) from serum-free medium conditioned with metastatic LuM1 cells with soluble factors known to stimulate gelatinase B secretion. Secretion of gelatinase B by LuM1 cells was augmented by tumor necrosis factor alpha, transforming growth factor beta1 (TGF-beta1), interleukin 1beta, or epidermal growth factor, and specific neutralizing antibodies abolished the induced increases. Platelet-derived growth factor and insulin-like growth factor 1 had no effect on gelatinase B secretion by LuM1 cells. The enhancement of gelatinase B secretion by fraction G was partially inhibited by the antibody to TGF-beta1. TGF-beta1 was detected in both active and latent forms in serum-free medium conditioned with LuM1 or NM11 cells, with the amount of TGF-beta1 higher in the former case. Gelatinase B secretion by LuM1 cells was enhanced by the addition of TGF-beta1 to the culture medium, but that by NM11 cells was not seriously affected, although the latter bound more of the factor. These results indicate the involvement of this growth factor in the autocrine stimulation of gelatinase B secretion by LuM1 cells. However, the autocrine factor effect was not fully explained by TGF-beta1 in the medium, and the involvement of some other unknown factor(s) was thus indicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764135

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Synergistic effect of indomethacin and bleomycin on tumor growth produced by activating antitumor immunity.

Authors:  R Matsushita; K Hattori; K Hayashi; H Iizasa; F Ichimura; E Nakashima
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.

Authors:  W C Duivenvoorden; H W Hirte; G Singh
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

Review 3.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Evaluation of the interaction between TGF beta and nitric oxide in the mechanisms of progression of colon carcinoma.

Authors:  Sylvia Lohm; Lucie Peduto-Eberl; Patricia Lagadec; Nicole Renggli-Zulliger; Jean Dudler; Jean-François Jeannin; Lucienne Juillerat-Jeanneret
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.

Authors:  S W Lin; M T Lee; F C Ke; P P Lee; C J Huang; M M Ip; L Chen; J J Hwang
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

6.  Dual role of SnoN in mammalian tumorigenesis.

Authors:  Qingwei Zhu; Ariel R Krakowski; Elizabeth E Dunham; Long Wang; Abhik Bandyopadhyay; Rebecca Berdeaux; G Steven Martin; LuZhe Sun; Kunxin Luo
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

7.  Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.

Authors:  Piotr Daniel; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Olga Stasikowska; Ewa Malecka-Panas
Journal:  Int J Colorectal Dis       Date:  2007-03-30       Impact factor: 2.571

8.  Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.

Authors:  X H Pei; Y Nakanishi; K Takayama; F Bai; N Hara
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

9.  Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.

Authors:  H M Collins; T M Morris; S A Watson
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

10.  Anti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer.

Authors:  Gabriela Figueroa-González; Verónica García-Castillo; Jossimar Coronel-Hernández; Eduardo López-Urrutia; Sonia León-Cabrera; Luis E Arias-Romero; L I Terrazas; Miriam Rodríguez-Sosa; Alma Delia Campos-Parra; Eduardo Zúñiga-Calzada; Cesar Lopez-Camarillo; Fermín Morales-González; Nadia J Jacobo-Herrera; Carlos Pérez-Plasencia
Journal:  J Cancer       Date:  2016-07-25       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.